Streetbeat News

Revenues

APLD

Applied Digital (NASDAQ:APLD) received 7 analyst ratings in the past three months, showing a mix of bullish sentiment despite a decrease in the average 12-month price target from $13.17 to $9.86, a 25.13% drop. Analysts from firms like B. Riley Securities, Lake Street, Roth MKM, and Needham have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Applied Digital's financial indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management were also discussed, highlighting its position and performance in the high performance computing industry.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:01 pm

MA

Recent analyst evaluations of Mastercard (NYSE:MA) show a mix of bullish and bearish perspectives, with a total of 13 analysts sharing their views over the past three months. The sentiment has shifted slightly towards more bullish in the last 30 days. The 12-month price targets suggest an upward trend, with an average target of $525.15, indicating a 2.08% increase from the previous average of $514.45. Mastercard, a leading payment processor, has shown impressive financial performance, including a revenue growth rate of 10.44% as of March 31, 2024, and a net margin of 47.43%. However, its debt-to-equity ratio of 2.16 indicates a higher level of financial risk.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:01 pm

OHI

Omega Healthcare Invts (NYSE:OHI) has received mixed analyst ratings over the past three months, with a recent shift towards a more positive outlook. Four analysts have provided ratings, with an updated average 12-month price target of $33.00, up from $31.33. The ratings range from 'Buy' to 'Neutral', with price targets adjusted upwards by analysts from Truist Securities, Citigroup, Wells Fargo, and Exane BNP Paribas. Omega's financial performance shows strong revenue growth, exceptional net margin, and efficient asset and equity management, indicating a positive trend for the company.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:00 pm

CVGI

Commercial Vehicle Group (NASDAQ:CVGI) received mixed analyst ratings over the past three months, with four somewhat bullish ratings in total and one in the last 30 days. The 12-month price target remains unchanged at $10.00. The company's financial performance shows a revenue decline of -5.04% over the past three months, but it outperforms in net margin, ROE, and ROA, with a lower than average debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:00 pm

BWA

BorgWarner (NYSE:BWA) has been analyzed by 10 analysts in the last three months, showing a range of opinions from bullish to bearish. Recent updates include raised price targets and ratings by several analysts, reflecting a positive outlook on the company's performance. The average 12-month price target for BWA has increased to $41.4, with a high estimate of $45.00 and a low estimate of $34.00. BorgWarner, a Tier I auto-parts supplier, has shown notable revenue growth and strong financial metrics, including a net margin of 5.73% and an ROE of 3.53%. The company's major customers include Ford and Volkswagen, and it has a significant market presence in Europe, Asia, and North America.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 6:00 pm

INTC

MU

The Biden administration's $280 billion CHIPS and Science Act aims to advance semiconductor technology by focusing on digital twins and establishing the CHIPS Manufacturing USA institute. This initiative will foster collaboration and resource-sharing among companies like Intel and Micron, which are among the beneficiaries of the act. The act supports the development of physical semiconductors and their virtual representations, enhancing innovation and training for the American workforce in this sector.

Portfolio Pulse from Franca Quarneti

May 06, 2024 | 5:46 pm

AMD

INTC

MU

NVDA

The Biden-Harris Administration announced a $285M funding opportunity for a CHIPS Manufacturing USA institute to develop digital twins technology for the semiconductor industry. This initiative, part of the 2022 Chips and Science Act, aims to advance U.S. chip technology and reduce dependence on international supply chains. Leading chipmakers like Nvidia, AMD, Intel, and Micron are involved, with Intel in talks for over $10B in subsidies and Micron signing a PMT for $6.1B in funding.

Portfolio Pulse from Shivani Kumaresan

May 06, 2024 | 5:41 pm

GOSS

Gossamer Bio Inc (NASDAQ:GOSS) has partnered with Italy's Chiesi Farmaceutici to develop and commercialize seralutinib for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The collaboration aims to advance lung health solutions globally, with both companies sharing development costs and commercial profits in the U.S. Chiesi will lead commercialization outside the U.S. and pay Gossamer up to $486 million in development, regulatory, and sales milestones.

Portfolio Pulse from Vandana Singh

May 06, 2024 | 5:17 pm

C

On CNBC, Citi CEO Jane Fraser provided insights into the current state of the consumer, offering valuable perspectives for investors and market watchers.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 5:16 pm

TCBP

TC BioPharm (NASDAQ:TCBP), a biotech firm, announced the exercise of warrants for £3.1 million in gross proceeds to fund an Acute Myeloid Leukemia trial and other expenses. The warrants allow the purchase of 1,750,000 ADSs at £1.5814 each. New warrants will also be issued, exercisable for 3,500,000 shares at £1.175 per ADS. H.C. Wainwright & Co. serves as the placement agent, with the offering expected to close by May 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 5:03 pm